Trial Details

COMPLETED
Basic Information
Clinical ID c4355
Identifier NCT00643071
Trial Title Tacrolimus (FK506) P-III, Open-label Study in Refractory Ulcerative Colitis Patients
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: Tacrolimus
Participant Information
Sponsor Astellas Pharma Inc
City Chūbu
Country/Region Japan
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2006-09
Primary Completion Date 2008-05
Completion Date 2008-05